Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,460 | -106,482 | -78,939 | -53,160 | -24,254 |
| Depreciation Amortization | 293 | 1,199 | 901 | 601 | 313 |
| Other Working Capital | 899 | 287 | 897 | 3,022 | -4,827 |
| Other Operating Activity | 3,614 | 14,576 | 11,068 | 7,480 | 3,632 |
| Operating Cash Flow | $-22,654 | $-90,420 | $-66,073 | $-42,057 | $-25,136 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -50 | -265 | -234 | -176 | -10 |
| Investing Cash Flow | $-50 | $-265 | $-234 | $-176 | $-10 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 61,971 | 19 | 19 | N/A |
| Other Financing Activity | -116 | -758 | -571 | -475 | -405 |
| Financing Cash Flow | $-116 | $61,213 | $-552 | $-456 | $-405 |
| Beginning Cash Position | 215,507 | 244,979 | 244,979 | 244,979 | 244,979 |
| End Cash Position | 192,687 | 215,507 | 178,120 | 202,290 | 219,428 |
| Net Cash Flow | $-22,820 | $-29,472 | $-66,859 | $-42,689 | $-25,551 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,654 | -90,420 | -66,073 | -42,057 | -25,136 |
| Capital Expenditure | -50 | -268 | -237 | -179 | -10 |
| Free Cash Flow | -22,704 | -90,688 | -66,310 | -42,236 | -25,146 |